Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis
Status:
Completed
Trial end date:
2018-03-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety, and dose-response relationship
of KLH-2109 compared to placebo in Japanese patients with endometriosis.